HEADER ONCOPROTEIN 23-OCT-20 7AQT TITLE NMR2 STRUCTURE OF BRD4-BD2 IN COMPLEX WITH IBET-762 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BRD4-BD2; COMPND 5 SYNONYM: PROTEIN HUNK1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS BRD4, BD2, BROMODOMAIN, IBET-762, NMR2, ONCOPROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR J.ORTS,F.TORRES,A.G.MILBRADT,R.WALSER REVDAT 3 27-APR-22 7AQT 1 JRNL REVDAT 2 13-APR-22 7AQT 1 JRNL REVDAT 1 02-MAR-22 7AQT 0 JRNL AUTH F.TORRES,R.WALSER,J.KADERLI,E.ROSSI,R.BOBBY,M.J.PACKER, JRNL AUTH 2 S.SARDA,G.WALKER,J.R.HITCHIN,A.G.MILBRADT,J.ORTS JRNL TITL NMR MOLECULAR REPLACEMENT PROVIDES NEW INSIGHTS INTO BINDING JRNL TITL 2 MODES TO BROMODOMAINS OF BRD4 AND TRIM24. JRNL REF J.MED.CHEM. V. 65 5565 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35357834 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01703 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT P. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AQT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1292110224. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.7 REMARK 210 IONIC STRENGTH : 150 REMARK 210 PRESSURE : 1 BAR REMARK 210 SAMPLE CONTENTS : 350 UM U-[12C,2H],U-15N,[13C,1H] REMARK 210 -ILE-D1, [13C,1H]-LEU-D1/2, [13C, REMARK 210 1H]-VAL-G1/2 ILV-BRD4-BD2, 50 MM REMARK 210 NA2HPO4, 500 UM [U-2H] TCEP, 420 REMARK 210 UM IBET-762, 100 % [U-2H] D2O, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-13C HSQC REMARK 210 ALIPHATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NMR2 REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 42 15.42 -145.80 REMARK 500 2 ASP A 42 15.41 -145.84 REMARK 500 3 ASP A 42 15.43 -145.81 REMARK 500 4 ASP A 42 15.44 -145.74 REMARK 500 5 ASP A 42 15.46 -145.87 REMARK 500 6 ASP A 42 15.40 -145.79 REMARK 500 7 ASP A 42 15.43 -145.87 REMARK 500 8 ASP A 42 15.40 -145.82 REMARK 500 9 ASP A 42 15.40 -145.78 REMARK 500 10 ASP A 42 15.43 -145.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAM A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34566 RELATED DB: BMRB REMARK 900 NMR2 STRUCTURE OF BRD4-BD2 IN COMPLEX WITH IBET-762 DBREF 7AQT A 4 112 UNP O60885 BRD4_HUMAN 351 459 SEQRES 1 A 109 SER GLU GLN LEU LYS CYS CYS SER GLY ILE LEU LYS GLU SEQRES 2 A 109 MET PHE ALA LYS LYS HIS ALA ALA TYR ALA TRP PRO PHE SEQRES 3 A 109 TYR LYS PRO VAL ASP VAL GLU ALA LEU GLY LEU HIS ASP SEQRES 4 A 109 TYR CYS ASP ILE ILE LYS HIS PRO MET ASP MET SER THR SEQRES 5 A 109 ILE LYS SER LYS LEU GLU ALA ARG GLU TYR ARG ASP ALA SEQRES 6 A 109 GLN GLU PHE GLY ALA ASP VAL ARG LEU MET PHE SER ASN SEQRES 7 A 109 CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU VAL VAL ALA SEQRES 8 A 109 MET ALA ARG LYS LEU GLN ASP VAL PHE GLU MET ARG PHE SEQRES 9 A 109 ALA LYS MET PRO ASP HET EAM A 201 52 HETNAM EAM 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2, HETNAM 2 EAM 4]TRIAZOLO[4,3-A][1,4]BENZODIAZEPIN-4-YL]-N- HETNAM 3 EAM ETHYLACETAMIDE FORMUL 2 EAM C22 H22 CL N5 O2 HELIX 1 AA1 SER A 4 ALA A 19 1 16 HELIX 2 AA2 HIS A 22 TRP A 27 1 6 HELIX 3 AA3 PRO A 28 TYR A 30 5 3 HELIX 4 AA4 ASP A 42 ILE A 47 1 6 HELIX 5 AA5 ASP A 52 ALA A 62 1 11 HELIX 6 AA6 ASP A 67 ASN A 86 1 20 HELIX 7 AA7 HIS A 90 MET A 110 1 21 SITE 1 AC1 8 TRP A 27 PRO A 28 LEU A 38 LEU A 40 SITE 2 AC1 8 CYS A 82 ASN A 86 HIS A 90 VAL A 92 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1